The majority of these biomarkers were lower in GC-naïve DMD patients relative to controls and either remained lower across the age span studied or further decreased with age or GC use (e.g. gelsolin, adiponectin, AGER). This evidence concerns the gene GSN and Duchenne muscular dystrophy.